MDK and neoplasm: MDK is expressed in a variety of tumor types (Jono & Ando, 2010; Sakamoto & Kadomatsu, 2012; Sorrelle et al, 2017), but it had not been pharmacologically targeted to prevent lymphovascular premetastatic niche activation (Olmeda et al, 2017; Sorrelle et al, 2017).